Pretomanid: First Approval
来源期刊:DrugsDOI:10.1007/s40265-019-01207-9
Entrectinib: First Global Approval
来源期刊:DrugsDOI:10.1007/s40265-019-01177-y
Gilteritinib: First Global Approval
来源期刊:DrugsDOI:10.1007/s40265-019-1062-3
Erenumab for Preventive Treatment of Migraine: A Systematic Review and Meta-Analysis of Efficacy and Safety
来源期刊:DrugsDOI:10.1007/s40265-019-01069-1
Erdafitinib: First Global Approval
来源期刊:DrugsDOI:10.1007/s40265-019-01142-9
Upadacitinib: First Approval
来源期刊:DrugsDOI:10.1007/s40265-019-01211-z
Rho-Associated Kinase Inhibitors: Evolving Strategies in Glaucoma Treatment
来源期刊:DrugsDOI:10.1007/s40265-019-01130-z
Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
来源期刊:DrugsDOI:10.1007/s40265-019-01095-z
Triamcinolone Acetonide Extended-Release: A Review in Osteoarthritis Pain of the Knee
来源期刊:DrugsDOI:10.1007/s40265-019-01083-3
Lenvatinib: A Review in Hepatocellular Carcinoma
来源期刊:DrugsDOI:10.1007/s40265-019-01116-x
24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients
来源期刊:DrugsDOI:10.1007/s40265-019-01248-0
Brolucizumab: First Approval
来源期刊:DrugsDOI:10.1007/s40265-019-01231-9
Sotagliflozin: First Global Approval
来源期刊:DrugsDOI:10.1007/s40265-019-01146-5
Tofacitinib: A Review in Psoriatic Arthritis
来源期刊:DrugsDOI:10.1007/s40265-019-01091-3
Clinical Overview of Enfortumab Vedotin in the Management of Locally Advanced or Metastatic Urothelial Carcinoma
来源期刊:DrugsDOI:10.1007/s40265-019-01241-7
Targeting EGFR and RAS/RAF Signaling in the Treatment of Metastatic Colorectal Cancer: From Current Treatment Strategies to Future Perspectives
来源期刊:DrugsDOI:10.1007/s40265-019-01113-0
Nutritional Psychiatry: From Concept to the Clinic
来源期刊:DrugsDOI:10.1007/s40265-019-01134-9
Emicizumab: A Review in Haemophilia A
来源期刊:DrugsDOI:10.1007/s40265-019-01200-2
Mechanism of Action and Clinical Attributes of Auryxia® (Ferric Citrate)
来源期刊:DrugsDOI:10.1007/s40265-019-01125-w
Lasmiditan: First Approval
来源期刊:DrugsDOI:10.1007/s40265-019-01225-7
Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review
来源期刊:DrugsDOI:10.1007/s40265-019-01173-2
Relugolix: First Global Approval
来源期刊:DrugsDOI:10.1007/s40265-019-01105-0
A Pharmacological Approach to Managing Inflammatory Bowel Disease During Conception, Pregnancy and Breastfeeding: Biologic and Oral Small Molecule Therapy
来源期刊:DrugsDOI:10.1007/s40265-019-01141-w
Current Concepts and Future Approaches in the Treatment of Cutaneous Lupus Erythematosus: A Comprehensive Review
来源期刊:DrugsDOI:10.1007/s40265-019-01151-8
As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?
来源期刊:DrugsDOI:10.1007/s40265-019-01202-0
Recent Clinical Advances in Pharmacotherapy for Levodopa-Induced Dyskinesia
来源期刊:DrugsDOI:10.1007/s40265-019-01170-5
Glycopyrronium/Formoterol: A Review in COPD
来源期刊:DrugsDOI:10.1007/s40265-019-01186-x
Immunotherapy Against Gliomas: is the Breakthrough Near?
来源期刊:DrugsDOI:10.1007/s40265-019-01203-z
Perioperative Pain Management in Morbid Obesity
来源期刊:DrugsDOI:10.1007/s40265-019-01156-3
Costimulation Blockade in Kidney Transplant Recipients
来源期刊:DrugsDOI:10.1007/s40265-019-01226-6
Sotagliflozin: A Review in Type 1 Diabetes
来源期刊:DrugsDOI:10.1007/s40265-019-01230-w
Poly (ADP-ribose) Polymerase Inhibition in Patients with Breast Cancer and BRCA 1 and 2 Mutations
来源期刊:DrugsDOI:10.1007/s40265-019-01235-5
Correction to: Mirogabalin: First Global Approval
来源期刊:DrugsDOI:10.1007/s40265-019-01082-4
Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
来源期刊:DrugsDOI:10.1007/s40265-019-1056-1
Correction to: Polatuzumab Vedotin: First Global Approval
来源期刊:DrugsDOI:10.1007/s40265-019-01214-w
Lusutrombopag: A Review in Thrombocytopenia in Patients with Chronic Liver Disease Prior to a Scheduled Procedure
来源期刊:DrugsDOI:10.1007/s40265-019-01197-8
Correction to: Benefit:Risk Profile of Budesonide in Obstructive Airways Disease
来源期刊:DrugsDOI:10.1007/s40265-019-01220-y
Immune Checkpoint Inhibition in Non-metastatic Non-small Cell Lung Cancer: Chance for Cure?
来源期刊:DrugsDOI:10.1007/s40265-019-01222-w
Distinct Profiles on Subjective and Objective Adherence Measures in Patients Prescribed Antidepressants
来源期刊:DrugsDOI:10.1007/s40265-019-01107-y
Correction to: Triamcinolone Aceonide Extended-Release: A Review in Osteoarthritis Pain of the Knee
来源期刊:DrugsDOI:10.1007/s40265-019-01109-w
Correction to: Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
来源期刊:DrugsDOI:10.1007/s40265-019-01111-2
Lanadelumab: A Review in Hereditary Angioedema
来源期刊:DrugsDOI:10.1007/s40265-019-01206-w
Correction to: Eravacycline: A Review in Complicated Intra-Abdominal Infections
来源期刊:DrugsDOI:10.1007/s40265-019-01117-w
Correction to: Tiotropium/Olodaterol: A Review in COPD
来源期刊:DrugsDOI:10.1007/s40265-019-01172-3
Correction to: Damoctocog Alfa Pegol: A Review in Haemophilia A
来源期刊:DrugsDOI:10.1007/s40265-019-01190-1
Acknowledgement to Referees
来源期刊:DrugsDOI:10.1007/s40265-019-01228-4
Correction to: Dapagliflozin: A Review in Type 2 Diabetes
来源期刊:DrugsDOI:10.1007/s40265-019-01239-1
Correction to: Revefenacin: First Global Approval
来源期刊:DrugsDOI:10.1007/s40265-019-01106-z
Correction to: Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax® Tetra/Flucelvax Quadrivalent®): A Review in the Prevention of Influenza
来源期刊:DrugsDOI:10.1007/s40265-019-01237-3
Correction to: Dapagliflozin: A Review in Type 1 Diabetes
来源期刊:DrugsDOI:10.1007/s40265-019-01238-2